ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 131 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $196,000 | +14.0% | 12,374 | -8.5% | 0.00% | 0.0% |
| Q1 2018 | $172,000 | -25.5% | 13,517 | -32.9% | 0.00% | -50.0% |
| Q4 2017 | $231,000 | +71.1% | 20,132 | +273.3% | 0.00% | +100.0% |
| Q2 2016 | $135,000 | +90.1% | 5,393 | +85.5% | 0.00% | – |
| Q1 2016 | $71,000 | -4.1% | 2,908 | +29.6% | 0.00% | -100.0% |
| Q4 2015 | $74,000 | -21.3% | 2,243 | -21.8% | 0.00% | 0.0% |
| Q3 2015 | $94,000 | +141.0% | 2,870 | +289.9% | 0.00% | – |
| Q2 2015 | $39,000 | – | 736 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,203 | $36,042,000 | 9.93% |
| Foresite Capital Management II, LLC | 1,043,832 | $12,787,000 | 5.18% |
| Redmile Group, LLC | 6,476,766 | $79,340,000 | 3.91% |
| DAFNA Capital Management LLC | 346,013 | $4,239,000 | 2.63% |
| Cormorant Asset Management, LP | 900,000 | $11,025,000 | 1.95% |
| SENZAR ASSET MANAGEMENT, LLC | 641,170 | $7,854,000 | 1.92% |
| Asymmetry Capital Management, L.P. | 105,228 | $1,289,000 | 1.50% |
| New Leaf Venture Partners, L.L.C. | 171,364 | $2,099,000 | 0.97% |
| EMERALD ADVISERS, LLC | 1,578,477 | $19,336,000 | 0.79% |
| BB BIOTECH AG | 2,266,008 | $27,759,000 | 0.77% |